Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Antimicrobial resistance (AMR)
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Antimicrobial resistance (AMR)
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Stop Big Pharma Profiteering

EU Governments - Protect our Meds not Their Monopolies
EU Governments - Protect our Meds not Their Monopolies
EU Governments - Protect our Meds not Their Monopolies

Read, watch, share

Statement
Statement |
16 June 2026
Research and development
European Union

European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access

Ministry of Health laboratory technician Allieu Tucker conducts a subculture test on patients’ samples in the laboratory of the MSF-supported Government Maternity and Children’s Hospital in Hangha, Kenema District, Sierra Leone.
Press release
Press release |
16 June 2026
Research and development
EuropeEuropean Union

Public investment demands public benefits: European Biotech Act must deliver for people

2 min
Maria Atonio, 43-years-old farmer from Macomia, returns home after visiting MSF’s Clinic in Nanga to receive ART treatment and to have a medical appointment with MSF’s clinical officer to monitor her health. Photo credit: MSF/Martim Gray Pereira
Press release
Press release |
19 March 2026
Pandemic preparedness Research and development
European Union

MSF calls on EU to unlock progress in final Pandemic Agreement talks

2 min
Letter
Letter |
16 March 2026
Research and development
European Union

Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all

"" Photo credit: Mudit Mathur
Press release
Press release |
05 March 2026
Intellectual property and trade
EuropeIndiaEuropean Union

DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance

4 min
02 December 2025
European Union

CSO Open Letter to European Parliament’s Committee on Public Health

YouTube Video (CAS5_nhi1IU)
Video
Video |
17 October 2025
Tuberculosis
European Union

MSF’s Panel Discussion: Bridging the gap: Securing access to essential TB medicines in the EU and EEA

Panel discussion in Brussels on how to improve the availability and affordability of TB medicines in the EU and EEA region. Shailly Gupta/MSF
Press release
Press release |
14 October 2025
Tuberculosis
EuropeEuropean Union

MSF urges EU and EEA to put TB back on the health agenda

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury